Fotagliptin
Fotagliptin is a Dipeptidyl Peptidase IV (DPP-4) inhibitor (IC50=2.27 nM) . Fotagliptin displays great security in rat and dog. Fotagliptin can be used for Type 2 diabetes mellitus research[1].
Product Specifications
CAS Number
[1312954-58-7]
Product Name Alternative
SAL067 (free base)
UNSPSC
12352005
Target
Dipeptidyl Peptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/fotagliptin.html
Purity
99.05
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C1=O)=NN=C(N2C[C@@H](CCC2)N)N1CC3=C(C=CC(F)=C3)C#N
Molecular Formula
C17H19FN6O
Molecular Weight
342.37
References & Citations
[1]Wang Z, et al. Development and validation of a UPLC-MS/MS method for simultaneous determination of fotagliptin and its two major metabolites in human plasma and urine. Bioanalysis. 2017 Feb;9 (4) :381-393.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
DPP-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
044210-ML550 100 µL
ZNF367, CT (ZNF367, ZFF29, Zinc finger protein 367, C2H2 zinc finger protein ZFF29) (MaxLight 550) discontinued
Ask
View Details 
MBS6289991-01 0.2 mL
CU002, CT (C21orf2, Uncharacterized protein C21orf2, C21orf-HUMF09G8.5, YF5/A2) (APC)
Ask
View Details MBS6289991-02 5x 0.2 mL
CU002, CT (C21orf2, Uncharacterized protein C21orf2, C21orf-HUMF09G8.5, YF5/A2) (APC)
Ask
View Details